ANTITHROMBOTIC THERAPY IN PATIENTS WITH AN INDICATION FOR ORAL ANTICOAGULATION AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT

Aspirin (ASA) + clopidogrel is recommended for 3-6 months following transcather aortic valve replacement (TAVR). Many patients undergoing TAVR also have an indication for oral anticoagulation (OAC). Antithrombotic regimens prescribed to these patients have not been well studied. Chart review of all